Skip to main content
. Author manuscript; available in PMC: 2023 Oct 4.
Published in final edited form as: Antiviral Res. 2023 Sep 15;218:105719. doi: 10.1016/j.antiviral.2023.105719

Table 3.

Role of the cell culture-selected Q136K substitution in NA-mediated binding of recombinant A(H3N2) viruses.

Source of NA NA amino acid at residue Infectivity (log10 IU/ml) Hemagglutination titer (HAU/50 μl)
NA-mediated binding
 
Turkey RBCsa
Guinea pig RBCs
136 148 150 439 − Oseb + Ose − Ose + Ose
A/Victoria/361/2011 Q T R R 8.1 ± 0.3 128 <2 512 2 Yes
Q T R T 8.2 ± 0.1 <2 <2 <2 <2 No
 
K
T
R
T
7.7 ± 0.1
64
<2
256
<2
Yes
A/Texas/50/2012 Q T H T 7.6 ± 0.3 <2 <2 <2 <2 No
Q T H R 8.0 ± 0.3 128 <2 512 2 Yes
 
K
T
H
T
6.7 ± 0.1
32
<2
128
2
Yes
A/Switzerland/9715293/2013 Q T R T 7.8 ± 0.3 <2 <2 <2 <2 No
Q T H R 7.9 ± 0.3 128 <2 512 2 Yes
K T R T 6.6 ± 0.3 32 <2 128 2 Yes

Recombinant PR8-based A(H3N2) viruses containing the NAs of the designated viruses were generated. Amino acid sequence at indicated positions were substituted (boldface) by site-directed mutagenesis.

a

RBCs, red blood cells.

b

Oseltamivir, 20 nM.